Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Portfolio Pulse from Lisa Levin
Several US stocks traded lower in Tuesday's pre-market session. Ventyx Biosciences, Alto Ingredients, Coherus BioSciences, Ameresco, Aura Biosciences, Clover Health Investments, Sanmina Corporation, Alpine Immune Sciences, ADTRAN Holdings, and Under Armour all recorded losses. The reasons for the decline include disappointing trial results, mixed Q3 financial results, downbeat Q3 results, weak quarterly sales, and wider-than-expected quarterly losses.
November 07, 2023 | 11:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ADTRAN Holdings shares fell 9.1% following a wider-than-expected quarterly loss.
The company's wider-than-expected quarterly loss led to a decrease in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Alpine Immune Sciences shares fell 9.4% after pricing its $150 million public offering of 8.8 million common shares at $12.50 per share.
The company's decision to price its public offering at $12.50 per share led to a decrease in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Alto Ingredients shares declined 52.4% after reporting mixed Q3 financial results.
The company's mixed Q3 financial results led to a decline in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Ameresco shares declined 18.4% following downbeat Q3 results.
The company's downbeat Q3 results led to a decline in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Aura Biosciences shares declined 15.5% after pricing its public offering of 11 million common shares at $9 per share.
The company's decision to price its public offering at $9 per share led to a decrease in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Coherus BioSciences shares dipped 18.9% after reporting mixed Q3 financial results.
The company's mixed Q3 financial results led to a decrease in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Clover Health Investments shares dropped 15.1% following weak quarterly sales.
The company's weak quarterly sales led to a decline in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Sanmina Corporation shares fell 12% after reporting worse-than-expected Q4 financial results.
The company's worse-than-expected Q4 financial results led to a decrease in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Under Armour shares declined 8.3% in pre-market trading.
The article does not provide a specific reason for the decline in Under Armour's stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Ventyx Biosciences shares tumbled 74% after disappointing Phase 2 trial results.
The company's Phase 2 trial results did not meet the internal target, which negatively impacted the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100